Article
Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study.
The Journal of antimicrobial chemotherapy - 29 May 2022
Jauneikaite Elita, Honeyford Kate, Blandy Oliver, Mosavie Mia, Pearson Max, Ramzan Farzan A, Ellington Matthew J, Parkhill Julian, Costelloe Céire E, Woodford Neil, Sriskandan Shiranee
Abstract excerpt
OBJECTIVES: Escherichia coli bloodstream infections have shown a sustained increase in England, for reasons that are unknown. Furthermore, the contribution of MDR lineages such as ST131 to overall E. coli disease burden and outcome is undetermined. METHODS: We genome-sequenced E. coli blood isolates from all patients with E. coli bacteraemia in north-west London from July 2015 to August 2016 and assigned MLST...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
